(Q37923958)

25 August 2017

1 reference

title

Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults (English)

1 reference

25 August 2017

1 reference

Madhuri Bajaj

1

1 reference

PubMed ID

21877997

25 August 2017

Elisabeth I Heath

series ordinal

2

1 reference

PubMed ID

21877997

25 August 2017

language of work or name

English

0 references

publication date

31 August 2011

1 reference

Expert Opinion on Biological Therapy

25 August 2017

1 reference

25 August 2017

11

1 reference

25 August 2017

11

1 reference

25 August 2017

1519-1524

1 reference

A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera

25 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.610788

Targeting death receptors in cancer with Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.610788

Promoting apoptosis as a strategy for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.610788

Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.610788

A novel receptor for Apo2L/TRAIL contains a truncated death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.610788

10.1517/14712598.2011.610788

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21877997